TLGT / Teligent Inc - SEC-arkiveringar, Årsredovisning, Fullmaktsutlåtande

TLGT / Teligent, Inc. / UBS OCONNOR LLC - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Teligent, Inc. (Name of Issuer) Common Stock, Par Value $0.01 Per Share (Title of Class of Securities) 87960W203 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule purs

Settlement Agreement, dated as of October 8, 2021, by and among Philip B. Yachmetz, the Company and the other parties thereto.

Exhibit 10.3 SETTLEMENT AGREEMENT AND GENERAL RELEASE This Settlement Agreement and General Release (the ?Agreement?) is made by and among: (i) Philip K. Yachmetz (?Executive?); (ii) Teligent, Inc. (the ?Company?); (iii) ACF FinCo I LP (?ACF?); and (iv) Ares Capital Corporation (?ACC? and, collectively with the Company and ACF, the ?Corporate Parties?) (Executive and the Corporate Parties are coll

Senior Secured Priming and Superpriority Debtor-in-Possession First Lien Credit Agreement, dated as of October 15, 2021 (the “DIP Credit Agreement”), by and among the Company, ACF Finco I LP, as administrative agent, ACF Finco I LP and Ares Capital Corporation, as DIP agents, and the lenders from time to time party thereto.

Exhibit 10.1 Execution Version Senior Secured Priming and Superpriority Debtor-in-Possession First Lien Credit Agreement by and among TELIGENT, INC., as Debtor, Debtor-in-Possession and Borrower, The Guarantors Party Hereto, The Lenders from Time to Time Party Hereto, ACF FINCO I LP, as Administrative Agent, and ACF FINCO I LP and ARES CAPITAL CORPORATION, as DIP Agents Dated as of October 15, 202

Teligent to Pursue Asset Sale through Voluntary Chapter 11 Process Company is arranging $12 million debtor-in-possession financing from its senior secured lenders and access to its cash collateral on a consensual basis Canadian entities to pursue sal

Exhibit 99.1 Teligent to Pursue Asset Sale through Voluntary Chapter 11 Process Company is arranging $12 million debtor-in-possession financing from its senior secured lenders and access to its cash collateral on a consensual basis Canadian entities to pursue sale process outside of Chapter 11 BUENA, NJ., October 14, 2021 ? Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharma

Amended and Restated Settlement Agreement, dated as of October 12, 2021, by and among Timothy B. Sawyer, the Company and the other parties thereto.

Exhibit 10.2 AMENDED AND RESTATED SETTLEMENT AGREEMENT AND GENERAL RELEASE This Amended and Restated Settlement Agreement and General Release (this ?Agreement?) is made by and among: (i) Timothy B. Sawyer (?Executive?); (ii) Teligent, Inc. (the ?Company?); (iii) ACF FinCo I LP (?ACF?); and (iv) Ares Capital Corporation (?ACC? and, collectively with the Company and ACF, the ?Corporate Parties?) (Ex

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Bankruptcy or Receivership

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 7, 2021 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Emplo

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 21, 2021 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Em

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 20, 2021 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Em

Amended and Restated Bylaws

Exhibit 3.1 Teligent, Inc. Bylaws AMENDED AND RESTATED BYLAWS OF TELIGENT, INC. (the ?Corporation?) Effective: September 20, 2021 Article 1 CERTIFICATES OF STOCK 1.1????????????Certificated and Uncertificated Shares of Stock. The shares of stock of the Corporation shall be represented by certificates unless the Board of Directors shall by resolution provide that some or all of any class or series

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-08568 Teligent, Inc.

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 21, 2021 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Employe

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-08568 Teligent, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K? ? Form 20-F ? Form 11-K x Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: March 31, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on

Letter from Deloitte & Touche LLP to the Securities and Exchange Commission, dated May 7, 2021

Exhibit 16.1 Deloitte & Touche LLP 100 Kimball Drive Parsippany, NJ 07054 Tel: +1 973 602 6000 www.deloitte.com May 7, 2021 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7561 Dear Sirs/Madams: We have read Item 4.01 of Teligent, Inc.?s Form 8-K/A dated May 7, 2021 and we agree with the statements made therein. Yours truly, /s/ Deloitte & Touche LLP Deloitte & Touche

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2021 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Employe

Description of Capital Stock (filed herewith)

DESCRIPTION OF CAPITAL STOCK OF TELIGENT, INC. The following is a summary of all material characteristics of our capital stock as set forth in our amended and restated certificate of incorporation, and amendments, and amended and restated bylaws. The summary does not purport to be complete and is qualified in its entirety by reference to our amended and restated certificate of incorporation, as am

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Exhibit 99.1 News From Buena, NJ 08310 Release Date: May 3, 2021 Contact: Philip Yachmetz Teligent, Inc. (856) 776-4632 [email protected] www.teligent.com TELIGENT, INC. ANNOUNCES 2020 YEAR-END EARNINGS REPORT AND PROVIDES BUSINESS UPDATE ? Significantly strengthened balance sheet and cash position ? Continued FDA Warning Letter remediation efforts ? Anticipate informing FDA on inspection rea

List of Subsidiaries (filed herewith)

Exhibit 21 List of Subsidiaries Subsidiary Jurisdiction of Formation Igen, Inc Delaware Teligent Pharma, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2021 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Employer

Annual Report - 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-08568 Teligent, Inc.

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 16, 2021 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Employ

Employment Agreement effective April 15, 2021 between the Company and Ernest R. De Paolantonio.

EXHIBIT 10.1 Execution Version EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement"), is dated as of the 8th day of April, 2021, by and between Teligent, Inc., having an address at 105 Lincoln Avenue, Buena, New Jersey 08310 (the ?Company?) and Ernest R. DePaolantonio, having an address at 4 Krista Court, Mendham, New Jersey 07945-3134 (the ?Executive?). The Company and the Executive ar

Teligent Announces Hiring of Chief Financial Officer

EXHIBIT 99.1 Teligent Announces Hiring of Chief Financial Officer Buena, N.J., April 15, 2021 (GLOBENEWSWIRE) - Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, today announced the hiring and appointment of Ernest R. De Paolantonio as Chief Financial Officer of the Company, effective April 15, 2021. Timothy B. Sawyer, Preside

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 9, 2021 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Employe

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 15, 2021 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Employ

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2021 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Employ

- NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): x Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: December 31, 2020 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report o

- PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: x Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2021 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Emp

Teligent, Inc. Announces Appointment of Carter Pate to Board of Directors Experienced Board Member and Investment Executive Joins Teligent, Effective Immediately

Exhibit 99.1 Teligent, Inc. Announces Appointment of Carter Pate to Board of Directors Experienced Board Member and Investment Executive Joins Teligent, Effective Immediately BUENA, NJ., February 23, 2021 – Teligent, Inc. (Nasdaq: TLGT), (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, today announced it has appointed Carter Pate to its Board of Directors

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 19, 2021 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Emp

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 22, 2021 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Emp

Teligent, Inc. Announces Appointment of Carter Pate to Board of Directors Experienced Board Member and Investment Executive Joins Teligent, Effective Immediately

Exhibit 99.1 Teligent, Inc. Announces Appointment of Carter Pate to Board of Directors Experienced Board Member and Investment Executive Joins Teligent, Effective Immediately BUENA, NJ., February 23, 2021 ? Teligent, Inc. (Nasdaq: TLGT), (?Teligent? or the ?Company?), a New Jersey-based specialty generic pharmaceutical company, today announced it has appointed Carter Pate to its Board of Directors

AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G

EXHIBIT A AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G The undersigned agree to file jointly with the Securities and Exchange Commission (the “SEC”) any and all statements on Schedule 13D or Schedule 13G (and any amendments or supplements thereto) required under section 13(d) of the Securities Exchange Act of 1934, as amended, in connection with purchases by the undersigned of the securities of any issuer.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G*/ (Rule 13d-102) Under the Securities Exchange Act of 1934 (Amendment No. 1)* Teligent, Inc. (Name of Issuer) Common stock, par value $0.001 per share (Title of Clas

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G*/ (Rule 13d-102) Under the Securities Exchange Act of 1934 (Amendment No. 1)* Teligent, Inc. (Name of Issuer) Common stock, par value $0.001 per share (Title of Class of Securities) 87960W203 (CUSIP Number) December 31, 2020 Date of Event Which Requires Filing of the Statement Check the appropriate box to designat

JOINT FILING AGREEMENT

EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the Statement on Schedule 13G/A filed herewith (and any amendments thereto), relating to the common stock of Teligent, Inc., a Delaware corporation, is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, as amended, on behalf of each of the undersig

Teligent, Inc. Announces Appointment of William S. Marth to Board of Directors Generic Pharmaceutical and Contract Manufacturing Industry Leader Joins Teligent Board, Effective Immediately

Exhibit 99.1 Teligent, Inc. Announces Appointment of William S. Marth to Board of Directors Generic Pharmaceutical and Contract Manufacturing Industry Leader Joins Teligent Board, Effective Immediately BUENA, NJ., February 16, 2021 – Teligent, Inc. (Nasdaq: TLGT), (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, today announced it has appointed industry v

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Teligent, Inc. (Name of Issuer) Common stock, $0.01 par value per share (Title of Class of Securities) (C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Teligent, Inc. (Name of Issuer) Common stock, $0.01 par value per share (Title of Class of Securities) 87960W203 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursu

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 15, 2021 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Emp

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 16, 2021 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Emp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Teligent, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Teligent, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 87960W203 (CUSIP Number) Kamran Moghtaderi, Eversept Partners, LP, 444 Madison Avenue, 22nd Floor, New York, NY 10022, 212-707-6113 (Name, Address an

Up to $50,000,000 of Common Stock

Filed Pursuant to Rule 424(b)(5) Registration No. 333-224188 Supplement No. 1 to Prospectus Supplement dated January 28, 2021 (to the Prospectus dated May 18, 2018) Up to $50,000,000 of Common Stock This supplement no. 1 dated February 16, 2021, supplements, modifies and supersedes, only to the extent indicated herein, certain information contained in our prospectus supplement dated January 28, 20

Teligent, Inc.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Teligent, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 87960W203 (CUSIP Number) December 31, 2020 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to whic

At Market Issuance Sales Agreement, dated as of January 27, 2021, by and among the Company and B. Riley Securities, Inc.

Exhibit 1.1 Execution Version TELIGENT, INC. Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement January 27, 2021 B. Riley Securities, Inc. 299 Park Avenue, 21st Floor New York, NY 10171 Ladies and Gentlemen: Teligent, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with B. Riley Securities, Inc. (the “Agent”) as follows: 1. Issuance

Form of Voting Trust Agreement, dated as of January 27, 2021, by and among the Company, Wilmington Savings Fund Society, FSB and the Holder party thereto.

Exhibit 10.3 Execution Version voting TRUST AGREEMENT This VOTING TRUST AGREEMENT (together with all schedules, exhibits and annexes hereto, this “Agreement”), dated as of January 27, 2021 (the “Effective Date”), between Teligent, Inc. a Delaware corporation (the “Company”), [MANAGER] (“Manager”), on behalf of the funds or accounts managed or sub-advised by them, severally and not jointly, as set

Exchange Agreement, dated as of January 27, 2021, by and among the Company, certain funds and accounts managed by affiliates of Ares Management Corporation, and the Participating Noteholders listed on the signature page thereto

Exhibit 10.1 Execution Version EXCHANGE AGREEMENT by and among TELIGENT, INC., the undersigned funds and accounts managed by affiliates of ARES MANAGEMENT CORPORATION and THE PARTICIPATING NOTEHOLDERS LISTED ON THE SIGNATURE PAGES HERETO Dated as of January 27, 2021 Schedules Schedule I: Exchange Shares (Series C Notes Exchange) Schedule II: Exchange Shares (Ares Loan Exchange) Exhibits Exhibit A:

Amendment No. 4 to First Lien Credit Agreement, dated as of January 27, 2021, by and among the Company, its subsidiaries signatory thereto, the lenders party thereto, and ACF Finco I LP, as Administrative Agent

Exhibit 10.5 EXECUTION VERSION AMENDMENT NO. 4 TO FIRST LIEN CREDIT AGREEMENT This AMENDMENT NO. 4 TO FIRST LIEN CREDIT AGREEMENT, dated as of January 27, 2021 (this “Amendment”), is by and among TELIGENT, INC., a Delaware corporation (the “Borrower”), the other Credit Parties signatory hereto, the lenders from time to time party hereto (each a “Lender” and, collectively, the “Lenders”), ACF FINCO

Up to $22,619,204 of Common Stock

424B5 1 tm213990d1424b5.htm 424B5 Filed Pursuant to Rule 424(b)(5) Registration No. 333-224188 PROSPECTUS SUPPLEMENT (to the Prospectus dated May 18, 2018) Up to $22,619,204 of Common Stock We have entered into an At Market Issuance Sales Agreement (the “Sales Agreement”) with B. Riley Securities, Inc. (“B. Riley Securities”) relating to the offer and sale of shares of our common stock, par value

Teligent Takes Strategic Steps to Recapitalize and Position Business for Success

Exhibit 99.1 Teligent Takes Strategic Steps to Recapitalize and Position Business for Success Completes $77 million debt-for-equity exchange with Series C noteholders and senior secured lenders at premiums of 60% and 30% to the 5 day VWAP Achieves aggregate reduction in debt of $118 million since June 30, 2020, resulting in current indebtedness of $105 million Gains access to $4.6 million in incre

Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock dated January 25, 2021

Exhibit 4.1 TELIGENT, inc. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES D CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE Delaware GENERAL CORPORATION LAW The undersigned, Timothy B. Sawyer and Philip K. Yachmetz, do hereby certify that: 1. They are the President and Secretary, respectively, of Teligent, Inc., a Delaware corporation (the “Corporation”). 2.

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2021 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Empl

Stockholders’ Agreement, dated as of January 27, 2021, by and among the Company, Ares Capital Corporation, each of the parties listed on Schedule A thereto, and, solely for purposes of Section 2, B. Riley Securities, Inc.

Exhibit 10.2 Execution Version STOCKHOLDERS’ AGREEMENT THIS STOCKHOLDERS’ AGREEMENT (this “Agreement”), is made as of January 27, 2021, by and among Teligent, Inc., a Delaware corporation (the “Company”), Ares Capital Corporation, a Maryland corporation, and each of the undersigned Affiliates thereof (collectively, “Ares”), each of the undersigned holders of Investor Exchange Shares (defined below

Amendment No. 6 to Second Lien Credit Agreement, dated as of January 27, 2021, by and among the Company, its subsidiaries signatory thereto, the lenders party thereto, and Ares Capital Corporation, as Administrative Agent

Exhibit 10.4 EXECUTION VERSION AMENDMENT NO. 6 TO SECOND LIEN CREDIT AGREEMENT This AMENDMENT NO. 6 TO SECOND LIEN CREDIT AGREEMENT, dated as of January 27, 2021 (this “Amendment”), is by and among TELIGENT, INC., a Delaware corporation (the “Borrower”), the other Credit Parties signatory hereto, the lenders from time to time party hereto (each a “Lender” and, collectively, the “Lenders”), ARES CA

Our Company

Exhibit 99.2 Teligent, Inc. discloses the information set forth below as of January 28, 2021, the date of this disclosure. Our Company Overview Teligent, Inc. is a generic pharmaceutical company that develops, manufactures and markets a diversified portfolio focused on high-barrier prescription products. Our mission is to become a leader in the generic pharmaceutical market. Under our own label, w

Letter from Deloitte & Touche LLP to the Securities and Exchange Commission, dated January 22, 2021

Exhibit 16.1 Deloitte & Touche LLP 100 Kimball Drive Parsippany, NJ 07054 Tel: +1 973 602 6000 www.deloitte.com January 22, 2021 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7561 Dear Sirs/Madams: We have read Item 4.01 of Teligent, Inc.’s Form 8-K dated January 22, 2021 and we agree with the statements made therein. Yours truly, /s/ Deloitte & Touche LLP Deloitte &

Teligent Regains Compliance with Nasdaq Filing Requirements and Nasdaq Minimum Market Value Rule

Exhibit 99.1 Teligent Regains Compliance with Nasdaq Filing Requirements and Nasdaq Minimum Market Value Rule Buena, N.J., JANUARY 22, 2021 (GLOBENEWSWIRE) - Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, previously received notice from The Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance with N

Financial Statements and Exhibits, Other Events - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 22, 2021 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Empl

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 22, 2021 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Empl

TELIGENT, INC. ANNOUNCES THIRD QUARTER 2020 RESULTS

News From Buena, NJ 08310 Release Date: December 31, 2020 Contact: Philip K. Yachmetz Teligent, Inc. (856) 776-4632 www.teligent.com TELIGENT, INC. ANNOUNCES THIRD QUARTER 2020 RESULTS BUENA, NJ - (GlobeNewswire) - Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter ended September 30, 2020. Financi

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-08568 Teligent, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2020 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction of incorporation) (Commission File N

Submission of Matters to a Vote of Security Holders - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2020 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Emp

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2020 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Empl

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 24, 2020 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Emp

- DEFA14A

DEFA14A 1 tm2037088d1defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (

JOINT FILING AGREEMENT

EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the Statement on Schedule 13G filed herewith (and any amendments thereto), relating to the common stock of Teligent, Inc., a Delaware corporation, is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, as amended, on behalf of each of the undersigne

87960W203 / TELIGENT INC / CITADEL ADVISORS LLC - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G*/ (Rule 13d-102) Teligent, Inc. (Name of Issuer) Common stock, par value $0.01 per share (Title of Class of Securities) 87960W203 (CUSIP Number) November 5, 2020 Date of Event Which Requires Filing of the Statement Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ¨ Rule 13d

- NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: September 30, 2020 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

87960W203 / TELIGENT INC / HIGHBRIDGE CAPITAL MANAGEMENT LLC - TELIGENT, INC. Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Teligent, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 87960W203 (CUSIP Number) September 29, 2020 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to which

Indenture, dated as of September 22, 2020, by and between the Company and Wilmington Savings Fund Society, FSB, as Trustee

Exhibit 4.1 EXECUTION VERSION Teligent, Inc. (Company) Wilmington Savings Fund Society, FSB (Trustee) Zero Coupon Convertible Senior Notes due 2023 INDENTURE Dated as of September 22, 2020 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 Section 1.01. Definitions and References. 1 Section 1.02. References to Interest. 12 Section 1.03. Acts of Holders. 13 A

Form of Series B Exchange Agreement, dated as of September 22, 2020, between the Company and the exchanging holder of Series B Convertible Notes party thereto

Exhibit 10.2 Execution Version EXCHANGE AGREEMENT This Exchange Agreement (this “Agreement”) is dated September 22, 2020 (the “Effective Date”), by and among each of the undersigned entities (the “Undersigned Entities” and each an “Undersigned Entity”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (“Accounts”), if any, for whom such Undersigned Entity holds contract

Teligent Announces Completion of Series D Convertible Note Exchange

Exhibit 99.1 Teligent Announces Completion of Series D Convertible Note Exchange Buena, N.J., SEPTEMBER 23, 2020 (GLOBENEWSWIRE) - Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the closing of the issuance of approximately $27.5 million aggregate principal amount of Zero Coupon Convertible Senior Notes due 2023 (t

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2020 TELIGENT, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2020 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Em

Form of Series A Exchange Agreement, dated as of September 22, 2020, between the Company and the exchanging holders of Series A Convertible Notes party thereto

Exhibit 10.1 Execution Version EXCHANGE AGREEMENT This Exchange Agreement (this “Agreement”) is dated September 22, 2020 (the “Effective Date”), by and among each of the undersigned entities (the “Undersigned Entities” and each an “Undersigned Entity”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (“Accounts”) for whom such Undersigned Entity holds contractual and i

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 14, 2020 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Em

TLGT / Teligent, Inc. / LIFE SCIENCES OPPORTUNITIES FUND II LP - AMENDMENT NO. 9 TO SCHEDULE 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D [Rule 13d-101] INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2(a) (Amendment No. 9)* Teligent, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 87960W104 (CUSIP Number) James C. Gale 152 West 57th Street,

- DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State

Restricted Stock Unit Agreement, by and between the Registrant and Philip Yachmetz, dated as of July 16, 2020.

EXHIBIT 99.3 RSU No. Teligent, Inc. Restricted Stock Unit (“RSU”) Grant Notice 1. Name and Address of Participant: PHILIP YACHMETZ 6 Timberline Lane Oakland, NJ 07436 2. Date of RSU Grant: July 16, 2020 3. Maximum Number of Shares for which this RSU is exercisable: 23,505 4. Exercise (purchase) price per share: $0 5. RSU Expiration Date: July 16, 2030 6. Vesting Start Date: July 16, 2021 7. Vestin

Non-Qualified Stock Option Agreement, by and between the Registrant and Timothy B. Sawyer, dated as of February 4, 2020.

EXHIBIT 99.1 Teligent, Inc. Non-Qualified Stock Option Grant Notice 1. Name and Address of Participant: Timothy Sawyer 31 Emerson Road Larchmont, NY 10538 2. Date of Option Grant: February 4, 2020 3. Maximum Number of Shares for which this Option is exercisable: 1,500,000 4. Exercise (purchase) price per share: $0.39 5. Option Expiration Date: February 4, 2030 6. Vesting Start Date: February 4, 20

- FORM S-8

As filed with the Securities and Exchange Commission on August 26, 2020 Registration No.

Non-Qualified Stock Option Agreement, by and between the Registrant and Philip Yachmetz, dated as of July 16, 2020.

EXHIBIT 99.2 Option No. Teligent, Inc. Non-Qualified Stock Option Grant Notice 1. Name and Address of Participant: PHILIP YACHMETZ 6 Timberline Lane Oakland, NJ 07436 2. Date of Option Grant: July 16, 2020 3. Maximum Number of Shares for which this Option is exercisable: 36,325 4. Exercise (purchase) price per share: $2.34 5. Option Expiration Date: July 16, 2030 6. Vesting Start Date: July 16, 20

- PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-08568 Teligent, Inc.

TELIGENT, INC. ANNOUNCES SECOND QUARTER 2020 RESULTS

News From Buena, NJ 08310 Release Date: August 19, 2020 Contact: Damian Finio Teligent, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 19, 2020 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction of incorporation) (Commission File Num

- NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: June 30, 2020 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Fo

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2020 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Employe

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 15, 2020 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Num

Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 15, 2020 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Employe

Consent and Amendment No. 3 to First Lien Credit Agreement, dated as of July 20, 2020, by and among the Company, its subsidiaries signatory thereto, the lenders party thereto, and ACF Finco I LP, as Administrative Agent

Exhibit 10.4 Execution Version AMENDMENT NO. 3 TO FIRST LIEN CREDIT AGREEMENT This AMENDMENT NO. 3 TO FIRST LIEN CREDIT AGREEMENT, dated as of July 20, 2020 (this “Amendment”), is by and among TELIGENT, INC., a Delaware corporation (the “Borrower”), its Subsidiaries signatory hereto, the lenders from time to time party hereto (each a “Lender” and, collectively, the “Lenders”), ACF FINCO I LP, a De

Teligent Announces Completion of Series C Convertible Note Financing and Exchange

Exhibit 99.1 Teligent Announces Completion of Series C Convertible Note Financing and Exchange Buena, N.J., JULY 20, 2020 (GLOBENEWSWIRE) - Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the closing of the issuance of $13.8 million aggregate principal amount of 9.5% Series C Senior Convertible Notes due 2023 (the

Exchange Agreement, dated as of July 20, 2020, between the Company, certain of its subsidiaries and the exchanging holders of Series B Convertible Notes party thereto

Exhibit 10.3 Execution Version EXCHANGE AGREEMENT This Exchange Agreement (this “Agreement”) is dated July 20, 2020 (the “Effective Date”), by and among each of the undersigned individuals or entities (the “Undersigned Entities” and each an “Undersigned Entity”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (“Accounts”) for whom such Undersigned Entity holds contrac

Form of Warrant, dated July 20, 2020, by and among the Company and the lenders party thereto

Exhibit 4.3 THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE TERMS HEREOF AND THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF OR OF A BENEFICIAL INTEREST HEREIN, THE HOLDER: (1) REPRESENTS THAT

Exchange Agreement, dated as of July 20, 2020, between the Company, certain of its subsidiaries and the exchanging holders of Series A Convertible Notes party thereto

EX-10.2 5 tm2024914d2ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 Execution Version EXCHANGE AGREEMENT This Exchange Agreement (this “Agreement”) is dated July 20, 2020 (the “Effective Date”), by and among each of the undersigned individuals or entities (the “Undersigned Entities” and each an “Undersigned Entity”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (“Accounts”) f

Teligent, Inc. Announces the Appointment of John Celentano as Chairman of the Board

EXHIBIT 99.1 Teligent, Inc. Announces the Appointment of John Celentano as Chairman of the Board BUENA, N.J., July 20, 2020 (GLOBE NEWSWIRE) - Teligent, Inc. (Nasdaq: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, is pleased to announce that John Celentano, a current independent director of Teligent, has been appointed Chairman of Teligent's Board

Indenture, dated as of July 20, 2020, by and among the Company, the Subsidiary Guarantors named therein, and Wilmington Trust, National Association, as Trustee and Collateral Agent

Exhibit 4.1 Execution Version Teligent, Inc. (Company) The Subsidiary Guarantors named herein (Subsidiary Guarantors) Wilmington Trust, National Association (Trustee and Collateral Agent) 9.5% Series C Senior Secured Convertible Notes due 2023 INDENTURE Dated as of July 20, 2020 Execution Version Table of Contents Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 7 Section 1.0

Consent and Amendment No. 5 to Second Lien Credit Agreement, dated as of July 20, 2020, by and among the Company, its subsidiaries signatory thereto, the lenders party thereto, and Ares Capital Corporation, as Administrative Agent

Exhibit 10.5 Execution Version AMENDMENT NO. 5 TO SECOND LIEN CREDIT AGREEMENT This AMENDMENT NO. 5 TO SECOND LIEN CREDIT AGREEMENT, dated as of July 20, 2020 (this “Amendment”), is by and among TELIGENT, INC., a Delaware corporation (the “Borrower”), its Subsidiaries signatory hereto, the lenders from time to time party hereto (each a “Lender” and, collectively, the “Lenders”), ARES CAPITAL CORPO

Form of Purchase Agreement, dated as of July 20, 2020, between the Company, certain of its subsidiaries and the purchasers party thereto

Exhibit 10.1 Execution Version July 20, 2020 Ladies and Gentlemen: Teligent, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Purchasers named on Schedule A hereto (the “Purchasers”), acting severally and not jointly, the Company’s 9.5% Series C Senior Secured Convertible Notes due 2023 (the “Series C Convertible Notes”) in the aggregate principal amount of $

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2020 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Employe

Teligent, Inc. Announces Hiring of Chief Legal Officer and Corporate Secretary

EXHIBIT 99.1 Contact: Damian Finio Teligent, Inc. (856) 336-9117 www.teligent.com Teligent, Inc. Announces Hiring of Chief Legal Officer and Corporate Secretary BUENA, N.J., July 17, 2020 (GLOBE NEWSWIRE) - Teligent, Inc. (Nasdaq: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, today announced the hiring of Philip Yachmetz as Chief Legal Officer an

Employment Agreement dated July 9, 2020 between the Company and Philip Yachmetz

EXHIBIT 10.1 Execution Version EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement"), is dated as of the 9th day of July 2020, by and between Teligent, Inc., having an address at 105 Lincoln Avenue, Buena, New Jersey 08310 (the “Company”) and Philip K. Yachmetz, having an address at 6 Timberline Lane, Oakland, New Jersey 07436 (the “Executive”). The Company and the Executive are collect

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 17, 2020 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Employe

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

- DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-08568 Teligent, Inc.

Certificate of Amendment to Amended and Restated Certificate of Incorporation of Teligent, Inc.

Exhibit 3.1 CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF TELIGENT, INC. TELIGENT, INC., a corporation duly organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify that: 1. The Amended and Restated Certificate of Incorporation of the Corporation, as amended to date, is hereby further amended by st

Regulation FD Disclosure, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 26, 2020 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Employer

Teligent Announces One-for-Ten Reverse Stock Split

Exhibit 99.1 Contact: Damian Finio Teligent, Inc. (856) 336-9117 www.teligent.com Teligent Announces One-for-Ten Reverse Stock Split Buena, N.J., MAY 26, 2020 (GLOBENEWSWIRE) - Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced today that as of 12:01 a.m., Eastern Time, on May 28, 2020 it will effect a one-for-ten rev

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2020 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction of incorporation) (Commission File Number

TELIGENT, INC. ANNOUNCES FIRST QUARTER 2020 RESULTS

Exhibit 99.1 News From Buena, NJ 08310 Release Date: May 22, 2020 Contact: Damian Finio Teligent, Inc. (856) 336-9117 www.teligent.com TELIGENT, INC. ANNOUNCES FIRST QUARTER 2020 RESULTS BUENA, NJ - (GlobeNewswire) - Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the first quarter ended March 31, 2020. First Qua

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2020 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdictionof incorporation) (Commission File Number)

Annual Report - FORM 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-

Amendment No. 2 dated July 18, 2019 to Second Lien Credit Agreement dated December 31, 2018 by and among the Company, certain subsidiaries, the lenders from time to time party thereto, and Ares Capital Corporation, as Administrative Agent (filed herewith).

aresamendno2secondliencr Execution Version AMENDMENT NO. 2 TO SECOND LIEN CREDIT AGREEMENT This AMENDMENT NO. 2 TO SECOND LIEN CREDIT AGREEMENT, dated as of July 18, 2019 and effective as of June 29, 2019 (this “Amendment”), is by and among TELIGENT, INC., a Delaware corporation (the “Borrower”), its Subsidiaries signatory hereto as guarantors or hereafter designated as Guarantors pursuant to Sect

Annual Report - 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-08568 Teligent, Inc.

List of Subsidiaries (

Exhibit 21 List of Subsidiaries Subsidiary Jurisdiction of Formation Igen, Inc. Delaware Teligent Pharma, Inc. Delaware Teligent Luxembourg S.a.r.l. Luxembourg Teligent OÜ Luxembourg Teligent Canada, Inc. British Columbia, Canada Microburst Energy, Inc. (Inactive) Delaware Blood Cells, Inc. (Inactive) Delaware Flavorsome, Ltd. (Inactive) Delaware Teligent Jersey Limited Jersey (U.K.) (dissolved 2/

Separation Agreement between the Company and Jason Grenfell-Gardner dated February 5, 2020 (filed herewith).

jggseparationagreement03

Amendment No. 1 dated February 8, 2018 to Second Lien Credit Agreement dated December 31, 2018 by and among the Company, certain subsidiaries, the lenders from time to time party thereto, and Ares Capital Corporation, as Administrative Agent (filed herewith).

aresamendno1secondliencr Execution Version AMENDMENT NO. 1 TO SECOND LIEN CREDIT AGREEMENT This AMENDMENT NO. 1 TO SECOND LIEN CREDIT AGREEMENT, dated as of February 8, 2019 (this “Amendment”), is by and among TELIGENT, INC., a Delaware corporation (the “Borrower”), its Subsidiaries signatory hereto as guarantors or hereafter designated as Guarantors pursuant to Section 8.11 of the Credit Agreemen

Description of Capital Stock

DESCRIPTION OF CAPITAL STOCK OF TELIGENT, INC. The following is a summary of all material characteristics of our capital stock as set forth in our amended and restated certificate of incorporation and amended and restated bylaws. The summary does not purport to be complete and is qualified in its entirety by reference to our amended and restated certificate of incorporation and amended and restate

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 6, 2020 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Employe

Form of Warrant, dated as of April 6, 2020, by and among the Company and the lenders party thereto (incorporated by reference to Exhibit 4.1 to the Company’s Report on Form 8-K filed April 8, 2020).

Exhibit 4.1 THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE TERMS HEREOF AND THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF OR OF A BENEFICIAL INTEREST HEREIN, THE HOLDER: (1) REPRESENTS THAT

Amendment No. 2 to First Lien Credit Agreement, dated as of April 6, 2020, by and among the Company, its subsidiaries signatory thereto, the lenders party thereto, and ACF Finco I LP, as Administrative Agent (incorporated by reference to Exhibit 10.1 to the Company’s Report on Form 8-K filed April 8, 2020).

Exhibit 10.1 Execution Version AMENDMENT NO. 2 TO FIRST LIEN CREDIT AGREEMENT This AMENDMENT NO. 2 TO FIRST LIEN CREDIT AGREEMENT, dated as of April 6, 2020 and effective as of December 31, 2019 (this “Amendment”), is by and among TELIGENT, INC., a Delaware corporation (the “Borrower”), its Subsidiaries signatory hereto, the lenders from time to time party hereto (each a “Lender” and, collectively

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 8, 2020 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction of incorporation) (Commission File Numbe

TELIGENT, INC. ANNOUNCES FOURTH QUARTER AND YEAR END 2019 RESULTS & AMENDMENTS TO EXISTING SECURED CREDIT FACILITIES

Exhibit 99.1 News From Buena, NJ 08310 Release Date: April 8, 2020 Contact: Damian Finio Teligent, Inc. (856) 697-4379 www.teligent.com TELIGENT, INC. ANNOUNCES FOURTH QUARTER AND YEAR END 2019 RESULTS & AMENDMENTS TO EXISTING SECURED CREDIT FACILITIES BUENA, NJ - (GlobeNewswire) - Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its finan

Amendment No. 4 to Second Lien Credit Agreement, dated as of April 6, 2020 by and among the Company, its subsidiaries signatory thereto, the lenders party thereto, and Ares Capital Corporation, as Administrative Agent (incorporated by reference to Exhibit 10.2 to the Company’s Report on Form 8-K filed April 8, 2020).

Exhibit 10.2 Execution Version AMENDMENT NO. 4 TO SECOND LIEN CREDIT AGREEMENT This AMENDMENT NO. 4 TO SECOND LIEN CREDIT AGREEMENT, dated as of April 6, 2020 and effective as of December 31, 2019 (this “Amendment”), is by and among TELIGENT, INC., a Delaware corporation (the “Borrower”), its Subsidiaries signatory hereto, the lenders from time to time party hereto (each a “Lender” and, collective

IG / Principal Investment Grade Corporate Active ETF NT 10-K - - NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: December 31, 2019 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report o

TLGT / Teligent, Inc. / Broadfin Capital, LLC Passive Investment

SC 13G/A 1 d8472746a13g-a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Teligent, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 87960W104 (CUSIP Number) December 31, 2019** (Date of Event Which Requires Filing of this Statement) Check the appropriate

AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G

EXHIBIT A AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G The undersigned agree to file jointly with the Securities and Exchange Commission (the “SEC”) any and all statements on Schedule 13D or Schedule 13G (and any amendments or supplements thereto) required under section 13(d) of the Securities Exchange Act of 1934, as amended, in connection with purchases by the undersigned of the securities of any issuer.

TLGT / Teligent, Inc. / venBio Select Advisor LLC - TELIGENT, INC. Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Teligent, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 87960W104 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to whic

TLGT / Teligent, Inc. / Prosight Management, LP - SC 13G/A Passive Investment

SC 13G/A 1 d879832dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* TELIGENT, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 87960W104 (CUSIP Number) December 31, 2019 (Date of Event which Requires Filing of this Statement) Check the app

TLGT / Teligent, Inc. / Eversept Partners, Llc - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Teligent, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 87960W104 (CUSIP Number) Kamran Moghtaderi, Eversept Partners, LP, 444 Madison Avenue, 22nd Floor, New York, NY 10022, 212-707-6113 (Name, Address an

Teligent, Inc. Announces Transition in Leadership

Exhibit 99.1 News From Buena, NJ 08310 Release Date: February 5, 2020 Teligent, Inc. Announces Transition in Leadership BUENA, N.J., February 5, 2020 (GLOBE NEWSWIRE) - Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, today announced a transition in leadership. Teligent has announced that Jason Grenfell-Gardner will be steppi

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 4, 2020 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Empl

Employment Agreement dated February 4, 2020 between the Company and Tim Sawyer (incorporated by reference to

Exhibit 10.1 Execution Version EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement"), is effective as of the 4th day of February 2020, by and between Teligent, Inc., having an address at 105 Lincoln Avenue, Buena, New Jersey 08310 (the "Company") and Tim Sawyer, having an address at 31 Emerson Road, Larchmont, New York 10538 (the "Executive"). The Company and the Executive are collectiv

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 24, 2020 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Empl

TLGT / Teligent, Inc. / Elk Creek Partners, LLC - ELK CREEK PARTNERS, LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* Teligent, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 87960W104 (CUSIP Number) December 31, 2019 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2020 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Emplo

Teligent, Inc. Change in Control Severance Policy (incorporated by reference to

Exhibit 10.1 FINAL Teligent, Inc. Change in Control Severance Policy Purpose The Board of Directors of Teligent, Inc. (the "Company") recognizes that the Company may experience a change of control, and that the possibility of a change of control may create uncertainty resulting in the loss or distraction of vital employees to the detriment of the Company and its stockholders. The Board also believ

IG / Principal Investment Grade Corporate Active ETF DEF 14A - - DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant  o Check the appropriate box:  o Preliminary Proxy Statement  o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy St

IG / Principal Investment Grade Corporate Active ETF PRE 14A - - PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant  o Check the appropriate box: ☒ Preliminary Proxy Statement  o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))  o Definitive Proxy St

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 26, 2019 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Emp

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 3, 2019 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (IRS Employe

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2019 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (IRS Employ

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-08568 Teligent, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2019 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction of incorporation) (Commission File Nu

TELIGENT, INC. ANNOUNCES THIRD QUARTER 2019 RESULTS

Exhibit 99.1 News From Buena, NJ 08310 Release Date: November 4, 2019 Contact: Damian Finio Teligent, Inc. (856) 336-9117 www.teligent.com TELIGENT, INC. ANNOUNCES THIRD QUARTER 2019 RESULTS BUENA, NJ - (GlobeNewswire) - Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter ended September 30, 2019. T

Form of Purchase Agreement, dated as of October 28, 2019, between the Company and the purchaser party thereto (incorporated by reference to Exhibit 10.1 to the Company’s Report on Form 8-K filed October 31, 2019).

Exhibit 10.1 October 28, 2019 [NAME OF PURCHASER] Ladies and Gentlemen: Pursuant to the terms and conditions of this Note Purchase Agreement (this “Agreement”), Teligent, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions hereof, to issue and sell to the purchaser identified on the signature page hereto (the “Purchaser”), the aggregate principal amount of t

Indenture, dated as of October 31, 2019, by and among the Company, certain subsidiary guarantors named therein, and Wilmington Trust, National Association, as Trustee

Exhibit 4.1 Execution Version Teligent, Inc. (Company) The Subsidiary Guarantors named herein (Subsidiary Guarantors) Wilmington Trust, National Association (Trustee) 7.0% Cash / 8.0% PIK Series B Senior Unsecured Convertible Notes due 2023 INDENTURE Dated as of October 31, 2019 1 Execution Version Table of Contents Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 6 Section 1

Consent and Amendment No. 3 to Second Lien Credit Agreement, dated as of October 31, 2019, by and among the Company, its subsidiaries signatory thereto, the lenders party thereto, and Ares Capital Corporation, as Administrative Agent

EX-10.4 6 tm1921567d1ex10-4.htm EXHIBIT 10.4 Exhibit 10.4 EXECUTION VERSION CONSENT AND AMENDMENT NO. 3 TO SECOND LIEN CREDIT AGREEMENT This CONSENT AND AMENDMENT NO. 3 TO SECOND LIEN CREDIT AGREEMENT, dated as of October 31, 2019 (this “Amendment”), is by and among TELIGENT, INC., a Delaware corporation (the “Borrower”), its Subsidiaries signatory hereto, the lenders from time to time party heret

Consent and Amendment No. 1 to First Lien Credit Agreement, dated as of October 31, 2019, by and among the Company, certain subsidiaries thereto, the lenders party thereto, and ACF Finco I LP, as Administrative Agent (incorporated by reference

Exhibit 10.3 EXECUTION VERSION CONSENT AND AMENDMENT NO. 1 TO FIRST LIEN CREDIT AGREEMENT This CONSENT AND AMENDMENT NO. 1 TO FIRST LIEN CREDIT AGREEMENT, dated as of October 31, 2019 (this “Amendment”), is by and among TELIGENT, INC., a Delaware corporation (the “Borrower”), its Subsidiaries signatory hereto, the lenders from time to time party hereto (each a “Lender” and, collectively, the “Lend

Form of Exchange Agreement, dated as of October 28, 2019, between the Company and the exchanging noteholder party thereto (incorporated by reference to Exhibit 10.2 to the Company’s Report on Form 8-K filed October 31, 2019).

Exhibit 10.2 FORM OF EXCHANGE AGREEMENT (the “Undersigned”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (“Accounts”) for whom the Undersigned holds contractual and investment authority (each Account, as well as the Undersigned if it is exchanging Old Notes (as defined below) hereunder, a “Holder”), enters into this Exchange Agreement (this “Agreement”) with Telige

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2019 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Empl

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2019 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Empl

Teligent Announces the Pricing of $34.4 Million of Series B Senior Convertible Notes

Exhibit 99.1 Teligent Announces the Pricing of $34.4 Million of Series B Senior Convertible Notes Buena, N.J., OCTOBER 28, 2019 (GLOBENEWSWIRE) - Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the pricing of $34,405,000 aggregate principal amount of its 7.0% Cash / 8.0% PIK Series B Senior Unsecured Convertible No

AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G

EXHIBIT A AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G The undersigned agree to file jointly with the Securities and Exchange Commission (the "SEC") any and all statements on Schedule 13D or Schedule 13G (and any amendments or supplements thereto) required under section 13(d) of the Securities Exchange Act of 1934, as amended, in connection with purchases by the undersigned of the securities of any issuer.

TLGT / Teligent, Inc. / Eversept Partners, Llc - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Teligent, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 87960W104 (CUSIP Number) Kamran Moghtaderi, Eversept Partners, LP, 444 Madison Avenue, 22nd Floor, New York, NY 10022, 212-707-6113 (Name, Address and T

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-08568 Teligent, Inc.

TELIGENT, INC. ANNOUNCES SECOND QUARTER 2019 RESULTS

Exhibit 99.1 News From Buena, NJ 08310 Release Date: August 5, 2019 Contact: Damian Finio Teligent, Inc. (856) 336-9117 www.teligent.com TELIGENT, INC. ANNOUNCES SECOND QUARTER 2019 RESULTS BUENA, NJ - (GlobeNewswire) - Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2019. Second

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2019 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction of incorporation) (Commission File Numb

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2019 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (IRS Employer o

Entry into a Material Definitive Agreement

8-K 1 tv5256488k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 18, 2019 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commissio

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2019 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (IRS Employer of

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2019 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (IRS Employer of

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-08568 Teligent, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2019 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction of incorporation) (Commission File Number)

TELIGENT, INC. ANNOUNCES FIRST QUARTER 2019 RESULTS

Exhibit 99.1 News From Buena, NJ 08310 Release Date: May 6, 2019 Contact: Damian Finio Teligent, Inc. (856) 336-9117 www.teligent.com TELIGENT, INC. ANNOUNCES FIRST QUARTER 2019 RESULTS BUENA, NJ - (GlobeNewswire) - Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the first quarter ended March 31, 2019. First Quar

April 11, 2019

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

April 3, 2019

DEFA14A 1 tv517957defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as

April 3, 2019

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

Separation Agreement, dated May 7, 2018, by and between the Company and Jenniffer Collins (incorporated by reference to Exhibit 33.1 to the Company’s Report on Form 10-Q, filed May 15, 2018).

May 7, 2018 Jenniffer Collins 12 Cherry Place Manasquan, New Jersey 08736 Dear Jenniffer: The purpose of this letter agreement (“Agreement and Release”) is to confirm the decision to terminate your employment with Teligent, Inc.

Annual Report - 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-08568 Teligent, Inc.

IG / Principal Investment Grade Corporate Active ETF NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: December 31, 2018 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report o

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2019 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction of incorporation) (Commission File Numb

TELIGENT, INC. ANNOUNCES FOURTH QUARTER AND YEAR END 2018 RESULTS

Exhibit 99.1 News From Buena, NJ 08310 Release Date: March 18, 2019 Contact: Damian Finio Teligent, Inc. (856) 697-4379 www.teligent.com TELIGENT, INC. ANNOUNCES FOURTH QUARTER AND YEAR END 2018 RESULTS BUENA, NJ - (GlobeNewswire) - Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the fourth quarter and year ended

TLGT / Teligent, Inc. / venBio Select Advisor LLC - TELIGENT, INC. Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Teligent, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 87960W104 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to whic

TLGT / Teligent, Inc. / Prosight Management, LP - SC 13G/A Passive Investment

SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* TELIGENT, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 87960W104 (CUSIP Number) December 31, 2018 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the

Entry into a Material Definitive Agreement

8-K 1 tv5130448k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2019 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commis

TLGT / Teligent, Inc. / Elk Creek Partners, LLC - ELK CREEK PARTNERS, LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Teligent, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 87960W104 (CUSIP Number) December 31, 2018 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 14, 2018 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction of incorporation) (Commission File N

TELIGENT, INC. EXECUTES $120 MILLION FINANCING AGREEMENT

Exhibit 99.1 News From Buena, NJ 08310 Release Date: December 13, 2018 Contact: Damian Finio Teligent, Inc. (856) 336-9117 www.teligent.com TELIGENT, INC. EXECUTES $120 MILLION FINANCING AGREEMENT BUENA, NJ – December 13, 2018 (GLOBE NEWSWIRE) — Teligent, Inc. (NASDAQ: TLGT), (“Teligent” or the “Company”) announced today that on December 13, 2018 the Company entered into a definitive first lien re

First Lien Revolving Credit Agreement, dated December 13, 2018, by and among the Company, certain Subsidiaries thereof, the Lenders from time to time party thereto, and ACF Finco LLP, as Administrative Agent (incorporated by reference to Exhibit 10.1 to the Company’s Report on Form 8-K, filed December 14, 2018).

Exhibit 10.1 Execution Version FIRST LIEN REVOLVING CREDIT AGREEMENT by and among TELIGENT, INC., as Borrower, Certain Subsidiaries thereof, as Guarantors, The Lenders from Time to Time Party Hereto, and ACF FINCO I LP, as Administrative Agent, Dated as of December 13, 2018 Article I Definitions 1 Section 1.01 Defined Terms 1 Section 1.02 Other Interpretive Provisions 39 Section 1.03 Accounting Te

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 13, 2018 TELIGENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (I.R.S. Emp

Second Lien Credit Agreement, dated December 13, 2018, by and among the Company, certain Subsidiaries thereof, the Lenders from time to time party thereto, and Ares Capital Corporation, as Administrative Agent (incorporated by reference to Exhibit 10.2 to the Company’s Report as Form 8-K, filed December 14, 2018).

Exhibit 10.2 EXECUTION VERSION NOTWITHSTANDING ANYTHING HEREIN TO THE CONTRARY, THE LIEN AND SECURITY INTEREST GRANTED TO THE ADMINISTRATIVE AGENT PURSUANT TO THIS AGREEMENT AND THE EXERCISE OF ANY RIGHT OR REMEDY BY THE ADMINISTRATIVE AGENT HEREUNDER ARE SUBJECT TO THE PROVISIONS OF THE INTERCREDITOR AGREEMENT, DATED AS OF DECEMBER 13, 2018 (AS AMENDED, RESTATED, AMENDED AND RESTATED, SUPPLEMENTE

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-08568 Teligent, Inc.

Quarterly Report - 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q/A (Amendment No.

The Company is filing a corrected copy of its Amended and Restated 2016 Equity Incentive Plan (the “2016 Plan”) as Exhibit [10.1] hereto, in the interest of correcting a typographical error that appeared in the previous filing of the 2016 Plan. No other changes have been made to the 2016 Plan.”

TELIGENT, INC. 2016 EQUITY INCENTIVE PLAN (as amended on May 21, 2018) 1 DEFINITIONS. Unless otherwise specified or unless the context otherwise requires, the following terms, as used in this Teligent, Inc. 2016 Equity Incentive Plan, have the following meanings: a. Administrator means the Board of Directors, unless it has delegated power to act on its behalf to the Committee, in which case the Ad

(incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q/A Amendment No. 1 for the quarter ended June 30, 2018 filed December 12, 2018

TELIGENT, INC. 2016 EQUITY INCENTIVE PLAN (as amended on May 21, 2018) 1. DEFINITIONS. Unless otherwise specified or unless the context otherwise requires, the following terms, as used in this Teligent, Inc. 2016 Equity Incentive Plan, have the following meanings: a. Administrator means the Board of Directors, unless it has delegated power to act on its behalf to the Committee, in which case the A

Separation Agreement

May 7, 2018 Jenniffer Collins 12 Cherry Place Manasquan, New Jersey 08736 Dear Jenniffer: The purpose of this letter agreement (“Agreement and Release”) is to confirm the decision to terminate your employment with Teligent, Inc.

Separation Agreement

May 7, 2018 Jenniffer Collins 12 Cherry Place Manasquan, New Jersey 08736 Dear Jenniffer: The purpose of this letter agreement (“Agreement and Release”) is to confirm the decision to terminate your employment with Teligent, Inc.

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2018 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction of incorporation) (Commission File N

TELIGENT, INC. RECEIVES NOTIFICATION OF DEFICICIENCY FROM NASDAQ RELATED TO THE DELAYED FILING OF FORM 10-Q

Exhibit 99.1 News From Buena, NJ 08310 Release Date: November 16th, 2018 TELIGENT, INC. RECEIVES NOTIFICATION OF DEFICICIENCY FROM NASDAQ RELATED TO THE DELAYED FILING OF FORM 10-Q BUENA, NJ – (PRNewswire) – Teligent, Inc. (NASDAQ: TLGT), on November 13, 2018 received a standard notice from NASDAQ stating that, as a result of not having timely filed its quarterly report on Form 10-Q for the quarte

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2018 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction of incorporation) (Commission File N

TELIGENT, INC. ANNOUNCES THIRD QUARTER 2018 RESULTS

Exhibit 99.1 News From Buena, NJ 08310 Release Date: November 13, 2018 Contact: Damian Finio Teligent, Inc. (856) 336-9117 www.teligent.com TELIGENT, INC. ANNOUNCES THIRD QUARTER 2018 RESULTS BUENA, NJ - (Globe Newswire) - Teligent, Inc. (NASDAQ: TLGT) (the "Company"), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter ended Sep

Commitment Letter, dated November 12, 2018, by and between the Company and Ares Management LLC (incorporated by reference to Exhibit 10.1 to the Company’s Report on Form 8-K, filed November 13, 2018).

Exhibit 10.1 Ares Management LLC 245 Park Avenue, 44th Floor New York, New York 10167 November 12, 2018 Teligent, Inc. 105 Lincoln Avenue Buena, NJ 08310 Attention: Damian Finio, CFO $25 MILLION FIRST LIEN REVOLVING CREDIT FACILITY $95 MILLION SECOND LIEN CREDIT FACILITIES COMMITMENT LETTER Mr. Finio: Thank you for contacting Ares Management LLC (together with its affiliates, “Ares”, “we” or “us”)

TELIGENT, INC. ANNOUNCES $120 MILLION FINANCING COMMITMENT FROM ARES

Exhibit 99.1 News From Buena, NJ 08310 Release Date: November 13, 2018 Contact: Damian Finio Teligent, Inc. (856) 336-9117 www.teligent.com TELIGENT, INC. ANNOUNCES $120 MILLION FINANCING COMMITMENT FROM ARES BUENA, NJ – November 13, 2018 (GLOBE NEWSWIRE) - Teligent, Inc. (NASDAQ: TLGT), (“Teligent” or the “Company”) announced today that the Company secured a financing commitment from funds manage

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2018 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction of incorporation) (Commission File N

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2018 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (IRS Employe

IG / Principal Investment Grade Corporate Active ETF NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: September 30, 2018 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2018 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction of incorporation) (Commission File Num

Letter from EisnerAmper LLP dated August 14, 2018.

Exhibit 16.1 August 14, 2018 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read Item 4.01 of Form 8-K dated August 14, 2018 of Teligent, Inc. and are in agreement with the statements contained in paragraph (a) therein as it regards our firm. We have no basis to agree or disagree with other statements of the registrant contained in Item 4.0

Separation Agreement

May 7, 2018 Jenniffer Collins 12 Cherry Place Manasquan, New Jersey 08736 Dear Jenniffer: The purpose of this letter agreement (“Agreement and Release”) is to confirm the decision to terminate your employment with Teligent, Inc.

The Company is filing a corrected copy of its Amended and Restated 2016 Equity Incentive Plan (the “2016 Plan”) as Exhibit [10.1] hereto, in the interest of correcting a typographical error that appeared in the previous filing of the 2016 Plan. No other changes have been made to the 2016 Plan.”

TELIGENT, INC. 2016 EQUITY INCENTIVE PLAN (as amended on May 21, 2018) 1. DEFINITIONS. Unless otherwise specified or unless the context otherwise requires, the following terms, as used in this Teligent, Inc. 2016 Equity Incentive Plan, have the following meanings: a. Administrator means the Board of Directors, unless it has delegated power to act on its behalf to the Committee, in which case the A

IG / Principal Investment Grade Corporate Active ETF JUNE 30, 2018 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-08568 Teligent, Inc.

TELIGENT, INC. ANNOUNCES SECOND QUARTER 2018 RESULTS

Exhibit 99.1 News From Buena, NJ 08310 Release Date: August 8, 2018 Contact: Damian Finio Teligent, Inc. (856) 336-9117 www.teligent.com TELIGENT, INC. ANNOUNCES SECOND QUARTER 2018 RESULTS BUENA, NJ - (Globe Newswire) - Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2018. Secon

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2018 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction of incorporation) (Commission File Numb

Credit Agreement, dated June 1, 2018, by and among the Company, the guarantors party thereto from time to time, each lender from time to time party thereto and Cantor Fitzgerald Securities (incorporated by reference to Exhibit 10.1 to the Company’s Report on Form 8-K, filed June 5, 2018).

Exhibit 10.1 EXECUTION VERSION CREDIT AGREEMENT Dated as of June 1, 2018 among TELIGENT, INC., as the Borrower, CERTAIN SUBSIDIARIES OF THE BORROWER PARTY HERETO, as the Guarantors, THE LENDERS PARTY HERETO and CANTOR FITZGERALD SECURITIES, as Administrative Agent TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND ACCOUNTING TERMS 1 1.1 Defined Terms. 1 1.2 Other Interpretive Provisions. 27 1.3 Acco

TELIGENT, INC. ANNOUNCES CLOSING OF $25 MILLION SECURED CREDIT FACILITY

Exhibit 99.1 News From Buena, NJ 08310 Release Date: June 5, 2018 Contact: Damian Finio Teligent, Inc. (856) 336-9117 www.teligent.com TELIGENT, INC. ANNOUNCES CLOSING OF $25 MILLION SECURED CREDIT FACILITY BUENA, N.J., June 5, 2018 (GLOBE NEWSWIRE) - TELIGENT, Inc. (NASDAQ: TLGT) Teligent, Inc. (“Teligent”) announced today that it has entered into a Credit Agreement with certain funds managed by

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2018 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (IRS Employer of

Teligent, Inc. 2016 Equity Incentive Plan, as amended.

Exhibit 10.1 TELIGENT, INC. 2016 EQUITY INCENTIVE PLAN (as amended, May 21, 2018) 1. DEFINITIONS. Unless otherwise specified or unless the context otherwise requires, the following terms, as used in this Teligent, Inc. 2016 Equity Incentive Plan, have the following meanings: a. Administrator means the Board of Directors, unless it has delegated power to act on its behalf to the Committee, in which

Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2018 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (IRS Employer of

IG / Principal Investment Grade Corporate Active ETF CORRESP

Teligent, Inc. 105 Lincoln Avenue Buena, New Jersey 08310 May 17, 2018 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Mail Stop 3561 Washington, D.C. 20549 Re: Teligent, Inc. Registration Statement on Form S-3 Filed April 6, 2018, as amended on May 4, 2018 File No. 333-224188 Dear Ms. Hayes: Pursuant to Rule 461 of the Rules and Regulations promulga

IG / Principal Investment Grade Corporate Active ETF CORRESP

CORRESP 1 filename1.htm Teligent, Inc. 105 Lincoln Avenue Buena, New Jersey 08310 May 16, 2018 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Mail Stop 3561 Washington, D.C. 20549 Re: Teligent, Inc. Registration Statement on Form S-3 Filed April 6, 2018, as amended on May 4, 2018 File No. 333-224188 Dear Ms. Hayes: Teligent, Inc. (the “Company”) her

IG / Principal Investment Grade Corporate Active ETF 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-08568 Teligent, Inc.

Separation Agreement

May 7, 2018 Jenniffer Collins 12 Cherry Place Manasquan, New Jersey 08736 Dear Jenniffer: The purpose of this letter agreement (“Agreement and Release”) is to confirm the decision to terminate your employment with Teligent, Inc.

IG / Principal Investment Grade Corporate Active ETF NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: March 31, 2018 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on F

IG / Principal Investment Grade Corporate Active ETF CORRESP

Teligent, Inc. 105 Lincoln Avenue Buena, New Jersey 08310 May 11, 2018 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Mail Stop 3561 Washington, D.C. 20549 Re: Teligent, Inc. Registration Statement on Form S-3 Filed April 6, 2018, as amended on May 4, 2018 File No. 333-224188 Dear Ms. Hayes: Pursuant to Rule 461 of the Rules and Regulations promulga

TELIGENT, INC. ANNOUNCES FIRST QUARTER 2018 RESULTS

Exhibit 99.1 News From Buena, NJ 08310 Release Date: May 8, 2018 Contact: Damian Finio Teligent, Inc. (856) 336-9117 www.teligent.com TELIGENT, INC. ANNOUNCES FIRST QUARTER 2018 RESULTS BUENA, NJ - (GlobeNewswire) - Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the first quarter ended March 31, 2018. First Quar

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2018 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction of incorporation) (Commission File Number)

TLGT / Teligent, Inc. / Prosight Management, LP - SC 13G Passive Investment

SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* TELIGENT, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 87960W104 (CUSIP Number) April 27, 2018 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule p

JOINT FILING AGREEMENT May 7, 2018

EX-99.1 Exhibit 99.1 JOINT FILING AGREEMENT May 7, 2018 Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended (the “Act”), and the rules and regulations thereunder, each party hereto hereby agrees to the joint filing, on behalf of each of them, of any filing required by such party under Section 13 or Section 16 of the Act or any rule or regulation thereunder (including

IG / Principal Investment Grade Corporate Active ETF S-3/A

S-3/A 1 tv491910s3a.htm S-3/A As filed with the Securities and Exchange Commission on May 4, 2018 Registration No. 333-224188 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 1 To FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorpo

IG / Principal Investment Grade Corporate Active ETF CORRESP

Joel I. Papernik | 212 692 6774 | [email protected] Chrysler Center 666 Third Avenue New York, NY 10017 212-935-3000 212-983-3115 fax www.mintz.com May 4, 2018 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Jeffrey Gabor Re: Teligent, Inc. Registration Statement on Form S-3 Filed April 6, 2018 File

Indenture, dated May 1, 2018, by and between the Company and Wilmington Trust, National Association, as trustee (incorporated by reference to Exhibit 10.1 to the Company’s Report on Form 8-K, filed May 2, 2018)

Exhibit 10.1 Teligent, Inc. (Company) Wilmington Trust, National Association (Trustee) 4.75% Convertible Senior Notes due 2023 INDENTURE Dated as of May 1, 2018 Article 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 Section 1.01. Definitions and References 1 Article 2 THE NOTES 11 Section 2.01. Title and Terms; Payments 11 Section 2.02. Ranking 11 Section 2.03. Denominations 12 Sectio

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2018 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (IRS Employer

Teligent, Inc. Announces Agreements to Exchange Approximately $65 million of its 3.75% Senior Convertible Notes Due 2019 for 4.75% Senior Convertible Notes Due 2023

Exhibit 99.2 Teligent, Inc. Announces Agreements to Exchange Approximately $65 million of its 3.75% Senior Convertible Notes Due 2019 for 4.75% Senior Convertible Notes Due 2023 Buena, NJ – April 27, 2018 – Teligent, Inc. (NASDAQ: TLGT; “Teligent”) announced today that it has entered into separate, privately negotiated exchange agreements with certain holders of Teligent’s 3.75% Senior Convertible

FORM OF EXCHANGE AGREEMENT

Exhibit 99.1 FORM OF EXCHANGE AGREEMENT (the “Undersigned”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (“Accounts”) for whom the Undersigned holds contractual and investment authority (each Account, as well as the Undersigned if it is exchanging Old Notes (as defined below) hereunder, a “Holder”), enters into this Exchange Agreement (this “Agreement”) with Telige

TLGT / Teligent, Inc. / Broadfin Capital, LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.

TLGT / Teligent, Inc. New FORM S-3

As filed with the Securities and Exchange Commission on April 6, 2018 Registration No.

Form of Subordinated Indenture.

Exhibit 4.4 TELIGENT, INC. Issuer AND [ ] Trustee INDENTURE Dated as of [ ] Subordinated Debt Securities CROSS-REFERENCE TABLE (1) Section of Trust Indenture Act of 1939, as Amended Section of Indenture 310(a). 7.09 310(b). 7.08 7.10 310(c). Inapplicable 311(a). 7.13(a) 311(b). 7.13(b) 311(c). Inapplicable 312(a). 5.02(a) 312(b). 5.02(b) 312(c). 5.02(c) 313(a). 5.04(a) 313(b). 5.04(a) 313(c). 5.04

Form of Senior Indenture.

Exhibit 4.3 TELIGENT, INC. Issuer AND [ ] Trustee INDENTURE Dated as of [ ] Senior Debt Securities CROSS-REFERENCE TABLE (1) Section of Trust Indenture Act of 1939, as Amended Section of Indenture 310(a). 7.09 310(b). 7.08 7.10 310(c). Inapplicable 311(a). 7.13(a) 311(b). 7.13(b) 311(c). Inapplicable 312(a) 5.02(a) 312(b). 5.02(b) 312(c). 5.02(c) 313(a). 5.04(a) 313(b). 5.04(a) 313(c). 5.04(a) 5.0

TLGT / Teligent, Inc. New DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confide

TLGT / Teligent, Inc. New DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

TLGT / Teligent, Inc. New 10-K (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-08568 Teligent, Inc.

TLGT / Teligent, Inc. New NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: December 31, 2017 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report o

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2018 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction of incorporation) (Commission File Numb

TELIGENT, INC. ANNOUNCES FOURTH QUARTER AND YEAR END 2017 RESULTS

Exhibit 99.1 News From Buena, NJ 08310 Release Date: March 15, 2018 Contact: Damian Finio Teligent, Inc. (856) 697-4379 www.teligent.com TELIGENT, INC. ANNOUNCES FOURTH QUARTER AND YEAR END 2017 RESULTS BUENA, NJ - (GlobeNewswire) - Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the fourth quarter and year ended

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2018 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (IRS Employer

TLGT / Teligent, Inc. New 10-Q/A (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q/A (Amendment No.

TLGT / Teligent, Inc. / venBio Select Advisor LLC - TELIGENT, INC. Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* Teligent, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 87960W104 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which th

POWER OF ATTORNEY

Exhibit 24 POWER OF ATTORNEY Know all by these present, that the undersigned hereby constitutes and appoints each of Jason Grenfell-Gardner and Martin Wilson of Teligent, Inc.

TLGT / Teligent, Inc. / Elk Creek Partners, LLC - ELK CREEK PARTNERS, LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Teligent, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 87960W104 (CUSIP Number) December 31, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule

Employment Agreement dated January 2, 2018 between the Company and Damian Finio (incorporated by reference to Exhibit 10.1 to the Company’s Report on Form 8-K filed January 26, 2018).

Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the ?Agreement?), is dated this 2nd day of January 2018, by and between Teligent, Inc. having an address at 33 South Wood Avenue, Suite 730, Iselin, New Jersey 08830 (the ?Company?) and Damian Finio having an address at 313 Partridge Road, Mountainside, New Jersey 07092 (the ?Executive?). The Company and the Executive are collectively re

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2018 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (IRS Employe

TELIGENT, INC. ANNOUNCES THE APPOINTMENT OF DAMIAN FINIO AS CHIEF FINANCIAL OFFICER

Exhibit 99.1 News From Buena, NJ 08310 Release Date: January 26, 2018 Contact: Martin Wilson Teligent, Inc. 856-336-9120 www.teligent.com TELIGENT, INC. ANNOUNCES THE APPOINTMENT OF DAMIAN FINIO AS CHIEF FINANCIAL OFFICER BUENA, NJ ? (PRNewswire) ? Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced today that Damian Finio has been appointed Chief

Regulation FD Disclosure, Financial Statements and Exhibits

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2018 TELIGENT, INC. (Exact name of registrant as specified in its charter) Delaware 001-08568 01-0355758 (State or other jurisdiction (Commission File Number) (IR

JP Morgan Healthcare Conference January 10, 2018 Jason Grenfell-Gardner │CEO Nasdaq Global Select: TLGT Safe Harbor 1 Except for historical facts, the statements in this presentation, as well as oral statements or other written statements made or to

tlgtjpminvestordeck11018 JP Morgan Healthcare Conference January 10, 2018 Jason Grenfell-Gardner ?CEO Nasdaq Global Select: TLGT Safe Harbor 1 Except for historical facts, the statements in this presentation, as well as oral statements or other written statements made or to be made by Teligent, Inc.